Search research articles
Contact Us
Filters
Showing results (101-110 of 169) with videos related to
Page
of 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 23, 2006
Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy
Ibrahim Yakoub-Agha, Florence Mesnil, Mathieu Kuentz, et al.
Blood
|
March 17, 2016
Comprehensive mutational profiling of core binding factor acute myeloid leukemia
Nicolas Duployez, Alice Marceau-Renaut, Nicolas Boissel, et al.
British Journal of Haematology
|
October 20, 2017
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies
Annalisa Paviglianiti, Annalisa Ruggeri, Fernanda Volt, et al.
Haematologica
|
October 26, 2010
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study
Mathilde Hunault-Berger, Thibaut Leguay, Xavier Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS
Arnaud Pigneux, Jean-Luc Harousseau, Francis Witz, et al.
Oncotarget
|
September 20, 2019
Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
Anne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Oncotarget
|
May 27, 2017
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
Anne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Blood
|
May 31, 2011
Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities
Aurore Perrot, Isabelle Luquet, Arnaud Pigneux, et al.
Blood
|
October 26, 2006
Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study
Adrienne de Labarthe, Philippe Rousselot, Françoise Huguet-Rigal, et al.
Journal of Hematology & Oncology
|
May 4, 2021
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
Mathieu Simonin, Aline Schmidt, Christophe Bontoux, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 169) with videos related to
Sort By:
Page
of 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 23, 2006
Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy
Ibrahim Yakoub-Agha, Florence Mesnil, Mathieu Kuentz, et al.
Blood
|
March 17, 2016
Comprehensive mutational profiling of core binding factor acute myeloid leukemia
Nicolas Duployez, Alice Marceau-Renaut, Nicolas Boissel, et al.
British Journal of Haematology
|
October 20, 2017
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies
Annalisa Paviglianiti, Annalisa Ruggeri, Fernanda Volt, et al.
Haematologica
|
October 26, 2010
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study
Mathilde Hunault-Berger, Thibaut Leguay, Xavier Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS
Arnaud Pigneux, Jean-Luc Harousseau, Francis Witz, et al.
Oncotarget
|
September 20, 2019
Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
Anne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Oncotarget
|
May 27, 2017
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
Anne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Blood
|
May 31, 2011
Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities
Aurore Perrot, Isabelle Luquet, Arnaud Pigneux, et al.
Blood
|
October 26, 2006
Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study
Adrienne de Labarthe, Philippe Rousselot, Françoise Huguet-Rigal, et al.
Journal of Hematology & Oncology
|
May 4, 2021
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
Mathieu Simonin, Aline Schmidt, Christophe Bontoux, et al.
Page
of 17